Alaiwi et al. report that of 1829 patients with RCC who were provided germline genetic testing, pathogenic or likely pathogenic variants in the FH gene were more common in AA patients, while the CHEK2 gene was more common in non-African patients [44]. This evidence concerns the gene CHEK2 and renal cell carcinoma.